Related Experiment Video
Updated: Aug 10, 2026

06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Proapoptotic Bid is required for pulmonary fibrosis
G R Scott Budinger1, Gökhan M Mutlu, James Eisenbart
1Department of Medicine, Northwestern University, Chicago, IL 60611, USA.
Summary
The proapoptotic protein Bid is essential for pulmonary fibrosis development. Bid-deficient mice show reduced lung scarring after bleomycin exposure, indicating Bid
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Cell Death Research
Background:
- Pulmonary fibrosis mechanisms remain unclear.
- Transforming growth factor-beta1 (TGF-β1) activation is crucial for fibrosis.
- The role of Bcl-2 family proteins in this process is not well-defined.
Purpose of the Study:
- To investigate the role of the Bcl-2 family member Bid in bleomycin-induced pulmonary fibrosis.
- To elucidate the molecular mechanisms linking TGF-β1 signaling to fibrosis development.
Main Methods:
- Intratracheal bleomycin instillation in wild-type (WT) and Bid-deficient (bid(-/-)) mice.
- Assessment of pulmonary fibrosis, inflammation, and lung injury.
- In vitro studies using alveolar epithelial cells to evaluate cell death pathways.
Main Results:
- Bid-deficient mice exhibited significantly reduced pulmonary fibrosis compared to WT mice.
- Similar levels of inflammation, lung injury, and active TGF-β1 were observed in both groups.
- Alveolar epithelial cells from bid(-/-) mice were resistant to TGF-β1-induced cell death, but not bleomycin-induced cell death.
Conclusions:
- Bid is a critical regulator of pulmonary fibrosis downstream of TGF-β1 activation.
- Bcl-2 family members play a key role in the pathogenesis of pulmonary fibrosis.
- Targeting Bid may offer a therapeutic strategy for pulmonary fibrosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
